A WORD FROM OUR LEADERSHIP
“We’re very optimistic that through our collective efforts, 2025 will bring new scientific understanding to TDD, expand on the amazing B-vitamin story, and continue down the path of helping all TDD patients live their best lives!”
Mike Morris
Co-Founder & President
Kasha Morris
Co-Founder & Secretary
“Together with our entire community, we continue to overcome challenges, looking toward a brighter future with optimism and hope.”
Ann Geffen
Executive Director
“Research is at the epicenter of finding a cure. Our international collaborations across various sectors are driving significant progress toward understanding and treating TANGO2 Deficiency Disorder. Together, we are committed to improving health outcomes and remain hopeful for a future cure!”
Deena Chisholm
Research Engagement Director
